Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 26, 2019
Actinium Highlights its Participation at the Upcoming Targeted Alpha Therapy International Symposium with Presentations on its AWE Platform, Clinical Programs and New Source of Ac-225 Isotope
NEW YORK, March 26, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM), announced today that two oral and four poster presentations related to its Ac-225 ...
March 26, 2019
MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018
YAVNE, Israel, March 26, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe ...
March 26, 2019
Scilex Holding, a Subsidiary of Sorrento Therapeutics, Announces Phase 2 Trial Results for its Leading SP-102 Program
MOUNTAIN VIEW, Calif., March 26, 2019 (GLOBE NEWSWIRE) -- Scilex Holdings, Inc. (“Scilex”), a majority owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), today ...
March 26, 2019
Prometic to Report its Fourth Quarter and 2018 Year-End Financial Results and Hold Conference Call / Webcast
LAVAL, QC , March 26, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic" or the "Corporation") announced today that it  will report its financial ...
March 21, 2019
Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results
VANCOUVER , March 21, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter ...
March 21, 2019
Chiasma Announces Three Poster Presentations at ENDO 2019
WALTHAM, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and ...
March 21, 2019
Opiant Pharmaceuticals, Inc. Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update
SANTA MONICA, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, ...
March 21, 2019
Conatus Announces Top-line Results from ENCORE-NF Phase 2b Clinical Trial in NASH Fibrosis
SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (CNAT) today announced top-line results from the company’s Phase 2b ENCORE-NF clinical trial in ...
March 21, 2019
BioInvent Unveils Broad Anti-TNFR2 Program to Treat Solid Tumors
LUND, Sweden , March 21, 2019 /PRNewswire/ --BioInvent International AB (OMXS:BINV), focused on the discovery and development of novel and first-in-class immuno-regulatory antibody-based medicines generated by ...
March 21, 2019
AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update
LAUSANNE, Switzerland, March 21, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on pioneering precision ...
March 21, 2019
Heat Biologics to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
DURHAM, NC / ACCESSWIRE / March 21, 2019 / Heat Biologics,Inc. (HTBX), a biopharmaceutical company developing immunotherapies designed to activate a patient's immune system against ...
March 21, 2019
Orchard Therapeutics Reports 2018 Financial Results and Reviews Recent Business Highlights
BOSTON and LONDON, March 21, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and ...
March 21, 2019
Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara™
VANCOUVER, March 21, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
March 21, 2019
aTyr Pharma Announces Poster Presentation at the 2019 American Association for Cancer Research (AACR) Annual Meeting
SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
March 21, 2019
DURECT Announces Patient Dosing in Phase 2a Proof-of-Concept Clinical Trial of Topical DUR-928 in Patients with Mild to Moderate Plaque Psoriasis
CUPERTINO, Calif., March 21, 2019 /PRNewswire/ -- DURECT Corporation (DRRX) today announced it has commenced patient dosing in a Phase 2a proof-of-concept trial with topical ...
March 21, 2019
BioLineRx to Report Annual 2018 Results on March 28, 2019
TEL AVIV, Israel, March 21, 2019 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today it will release its audited annual financial ...
March 21, 2019
Lipocine to Participate at the ROTH Battle of the NASH Thrones Spring Investor Conference
SALT LAKE CITY, March 21, 2019 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will provide ...
March 21, 2019
PolarityTE Hosts Symposium Featuring SkinTE-Treated Burn Survivor, New Clinical Data at American Burn Association Annual Meeting
SALT LAKE CITY, March 21, 2019 /PRNewswire/ -- PolarityTE, Inc. (PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today it will ...
March 21, 2019
CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 21, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products ...
March 21, 2019
Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Officer
BOSTON, March 21, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
Page 4 of 138